Project Grant G2649914

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $180,059 to the Research Institute at Nationwide Children's Hospital (RINCH) to study the developmental outcomes of children with neonatal opioid withdrawal syndrome (NOWS). The key objectives are to: 1) engage a community advisory board to identify patient-centered outcomes and intervention approaches, 2) assess the independent and moderating...

The U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) awarded a $3,000,000 Project Grant to The Center For Wellness And Recovery Of Northeast GA Corp under the Rural Health Research Centers program (CFDA 93.155). The grant, titled "RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-IMPACT", began on September 1, 2024 and is scheduled for completion on August 31, 2028. The project aims to support policy-relevant research and technical...

The University of New Mexico Health Sciences Center (UNM HSC) was awarded a $3,900,000 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Congressional Directives program (CFDA 93.493). The grant funding aims to expand capacity and support best practices in caring for infants with neonatal opioid withdrawal syndrome (NOWS) in rural New Mexico. Key objectives include: Providing training and quality improvement coaching to healthcare providers at...

The $3,000,000 Rural Communities Opioid Response Program-Impact project grant was awarded by the Federal Office of Rural Health Policy on September 1, 2024 to ST. Mary's Community Hospital in Nebraska City, Nebraska. This 4-year grant, which runs through August 31, 2028, is funded under the Rural Health Research Centers program (CFDA 93.155). The grant supports policy-relevant research and technical assistance aimed at understanding and improving healthcare in rural communities, with a focus...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $368,315 to the Georgia State University Research Foundation Inc. to design and test a novel rat model of the neonatal intensive care unit (NICU) experience. The project aims to delineate the mechanisms by which early adverse experiences in the NICU, including pain, resource scarcity, and separation from caregivers, can increase the risk of...

This Project Grant award from the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279) provides $945,397 to the Magee-Womens Research Institute and Foundation to adapt and evaluate a Collaborative Care Model (CCM) for pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The award has two main goals: 1) to adapt an existing CCM for rural and low-resource obstetric settings, and 2) to evaluate the effects of...

The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...

The Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded the Nevada Department of Health and Human Services a $83,174,470 Project Grant to implement the Nevada State Opioid Response (SOR) program. The program aims to combat the opioid and stimulant crisis by expanding treatment access, enhancing prevention strategies, strengthening harm...

The Reno-Sparks Indian Colony (RSIC) was awarded a $386,902 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The purpose of the grant is to implement an intensive outpatient treatment program to address opioid use disorders among American Indian/Alaskan Native populations in northern Nevada. Key objectives of the 5-year project...

This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...